Affiliate disclosure: This article contains affiliate links. If a purchase is made through these links, a commission may be earned at no additional cost to you. This does not influence our editorial conclusions. Content is for informational and educational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any supplement, especially if you take prescription medications.
SterlingMedicalCenter.org Editorial Team | Wellness Supplement Reviews | 2026
Memopryl Ingredients: Evidence Review of All 8 Compounds
This article is the deep-dive companion to the Memopryl review. Where the main review covers the full product evaluation including pricing, refund policy, and fit assessment, this piece is focused entirely on the eight ingredients — what the research shows about each one, how they interact within the formula, and what the dosage transparency gap actually means for a prospective buyer. Every ingredient section is grounded in ingredient-level research only. No clinical trial on the finished Memopryl formula is publicly available.
One safety note belongs at the top of any Memopryl ingredient discussion: this formula contains St. John's Wort, which carries a prescription medication interaction profile that requires physician or pharmacist review before use for anyone on any prescription drug. The full clinical detail is covered in the final section of this review and in the dedicated Memopryl drug interactions and safety review.
The Dosage Transparency Gap: Why It Matters for This Analysis
Specific per-ingredient milligram dosages are not publicly disclosed on the official Memopryl website or in any accessible brand documentation. This is a structural limitation on how deeply any independent analysis can go. For every ingredient below, the SMC Research Desk documents the dosage ranges used in published research. Whether Memopryl's formula delivers those ingredients at clinically studied levels is unknown. That is not a dismissal — it is an honest description of what the evidence permits and what it does not.
Premium nootropics outside the ClickBank distribution model — products like Mind Lab Pro, for example — typically publish full per-ingredient dosages, allowing direct comparison against research protocols. The absence of that transparency in Memopryl is a real differentiator that belongs in any honest ingredient review. For broader context on what dosage transparency means for supplement evaluation, see our nootropic ingredients and brain health research overview.
Ginkgo Biloba
Ginkgo Biloba extract is among the most studied botanical compounds in cognitive health literature. Its primary proposed mechanisms involve support for cerebral blood flow through vasodilation and antioxidant protection of neuronal tissue via flavonoid and terpenoid compounds. The evidence base is large and genuinely heterogeneous — outcomes vary substantially based on extract standardization, dose, population studied, and duration.
Research on the EGb 761 standardized extract — the form used in the most rigorous trials — has used doses of 120 mg to 240 mg per day. The GEM study, one of the largest prevention trials, examined Ginkgo in healthy older adults and found limited benefit for cognitive decline prevention. Other trials, particularly in populations already experiencing mild cognitive concerns, have reported more supportive outcomes for specific domains including attention and memory. The practical implication: Ginkgo's research is more consistent in maintenance contexts than enhancement contexts, and in standardized extract forms at adequate doses.
Safety note: Ginkgo Biloba has mild anticoagulant activity and is contraindicated for adults taking blood thinners, antiplatelet medications, or regular aspirin without physician guidance.
Phosphatidylserine
Phosphatidylserine (PS) is a phospholipid that is a natural component of brain cell membranes. Its structural role involves maintaining cellular integrity and facilitating the efficient release and signaling of neurotransmitters. The FDA has acknowledged a qualified health claim for phosphatidylserine related to cognitive function and reduced risk of dementia — with the explicit qualifier that the evidence is “limited and not conclusive.”
That qualification is precise and meaningful. PS is one of very few supplement ingredients to reach even a qualified FDA threshold. Research has investigated PS at doses typically ranging from 100 mg to 300 mg per day. Its role in supporting synaptic plasticity and cholinergic function has been examined across several populations, including older adults experiencing age-related cognitive change. Without disclosed dosage information from Memopryl, comparison against these studied ranges is not possible.
Bacopa Monnieri Extract
Bacopa Monnieri has the most consistent and well-replicated human clinical research base of the eight ingredients in Memopryl. Its active compounds — bacosides — have been examined across multiple randomized controlled trials with outcomes focused on memory acquisition, attentional speed, and cognitive performance over time. A 2014 meta-analysis in the Journal of Ethnopharmacology reviewing 9 RCTs with 518 subjects found that standardized Bacopa extract showed potential to improve cognition, particularly speed of attentional processing.
Two research-specific points matter for realistic expectations. Clinical trials have used standardized extracts with defined bacoside content — typically 20% to 55% standardization — at doses of 300 mg to 450 mg per day for minimum 12-week periods. Effects in published research are consistently cumulative, not acute. Adults evaluating a Bacopa-containing supplement over two to three weeks are not operating within the time window the research was designed around. A 60-day evaluation window is closer to the minimum for a fair assessment of this ingredient specifically.
N-Acetyl-L-Carnitine (ALCAR)
N-Acetyl-L-Carnitine crosses the blood-brain barrier more efficiently than standard L-Carnitine due to its acetylated form. It has been studied for its role in mitochondrial energy metabolism — facilitating fatty acid transport into neuronal mitochondria — and for potential neuroprotective effects, including interactions with nerve growth factor (NGF) signaling. Its cholinergic pathway connections (it can serve as a precursor to acetylcholine) place it in the same broad system as Alpha-GPC and Huperzine-A.
Research doses for ALCAR have varied widely, from 500 mg to 2,000 mg per day, depending on the study design and outcome measured. The ingredient's research profile is most relevant to adults experiencing mental fatigue and reduced cognitive stamina rather than acute memory difficulties. It represents a different mechanism than the memory-encoding focus of Bacopa or the direct cholinergic support of Alpha-GPC.
St. John's Wort
St. John's Wort's inclusion in a nootropic formula reflects the documented mood-cognition relationship. Emotional depletion, sustained stress, and low mood all have measurable effects on cognitive performance — this is physiologically established, not marketing language. The ingredient's active compounds, hypericin and hyperforin, have been studied for their interactions with serotonin and dopamine signaling pathways. Its mood-support research has primarily been conducted at 300 mg per day of standardized extract (typically 0.3% hypericin).
The safety profile must be stated in full. St. John's Wort is a potent inducer of cytochrome P450 enzymes — specifically CYP3A4, CYP2C9, and P-glycoprotein — the primary liver pathways used to metabolize many prescription medications. This mechanism can significantly reduce plasma concentrations of numerous prescription drugs or alter their pharmacokinetic profiles in clinically meaningful ways. Affected drug classes include SSRIs and MAOIs (risk of serotonin syndrome), warfarin and other blood thinners, oral contraceptives, immunosuppressants (including tacrolimus and cyclosporine used post-transplant), certain HIV medications (protease inhibitors and non-nucleoside reverse transcriptase inhibitors), some anticonvulsants, and digoxin. The NCCIH categorizes St. John's Wort as one of the most clinically significant herb-drug interactions in the supplement category. This is not a standard supplement caution. It is an interaction concern that requires physician or pharmacist review before use for any adult taking prescription medications. See the full Memopryl drug interaction review for complete clinical detail.
L-Glutamine
L-Glutamine is the most abundant free amino acid in the bloodstream and a key precursor for both glutamate and GABA — the primary excitatory and inhibitory neurotransmitters respectively. The balance between glutamate and GABA activity underlies focused attention, the ability to filter cognitive noise, and the quality of sustained concentration. Research has explored its role in supporting brain energy homeostasis during high-demand cognitive periods and in stress states. Typical research doses range from 5 g to 10 g per day, primarily in studies examining gut health and recovery contexts — cognitive-specific dosing is less standardized in the literature.
Alpha-GPC (Alpha-Glycerophosphorylcholine)
Alpha-GPC is the most bioavailable choline precursor available in supplement form. It crosses the blood-brain barrier efficiently, delivering choline directly to the brain where it is converted into acetylcholine. This makes it one of the more mechanistically direct ingredients in the nootropic category — it supports a specific, well-characterized neurochemical process rather than operating through a broad or theoretical pathway.
Research has examined Alpha-GPC in a range of populations and outcomes, including cognitive performance during demanding tasks, cholinergic function support, and potential neuroprotective roles. Doses in clinical research have typically ranged from 300 mg to 600 mg per day. The combination of Alpha-GPC and Huperzine-A — production support plus breakdown inhibition — represents a coherent dual-pathway approach to maintaining acetylcholine availability.
Huperzine-A
Huperzine-A is a natural alkaloid from Huperzia serrata (firmoss). Its primary studied mechanism is reversible inhibition of acetylcholinesterase — the enzyme that breaks down acetylcholine. By slowing this process, Huperzine-A supports sustained acetylcholine availability without directly increasing production. In combination with Alpha-GPC, this creates a coordinated approach to cholinergic support from both ends of the cycle.
Research has used doses typically ranging from 50 mcg to 200 mcg per day. Huperzine-A's mechanism is mechanistically similar to pharmaceutical acetylcholinesterase inhibitors used in prescription Alzheimer's treatment (donepezil, rivastigmine, galantamine) — though Huperzine-A is a dietary supplement and is not FDA-approved for any clinical indication. This similarity has led some reviewers to note that the triple cholinergic load from Alpha-GPC, ALCAR, and Huperzine-A together warrants attention for adults already on prescription cholinergic medications. This is covered in the Memopryl safety and drug interactions review.
Formula Architecture Assessment
Taken together, Memopryl's formula covers four distinct mechanistic angles: cholinergic pathway support (Alpha-GPC, ALCAR, Huperzine-A), membrane integrity and phospholipid support (Phosphatidylserine), cerebrovascular and antioxidant support (Ginkgo Biloba), and adaptogenic/cumulative cognitive support (Bacopa Monnieri). L-Glutamine addresses neurotransmitter balance, and St. John's Wort addresses the mood-cognition axis. This is a coherent multi-pathway architecture by design rather than an arbitrary collection of popular ingredients.
The critical limitation — absent per-ingredient dosage disclosure — prevents confirming whether each of these mechanisms is adequately dosed relative to the research protocols that established each ingredient's potential. For adults for whom that confirmation matters, this transparency gap is a genuine reason to consider alternatives that publish full label data. For adults satisfied with the ingredient rationale and prepared for the cumulative time window the research requires, the formula's architecture is mechanistically sound. For a comparison of how Memopryl positions against other 2026 nootropic options, see the best nootropic supplements 2026 comparison.
These statements have not been evaluated by the Food and Drug Administration. Memopryl is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any supplement.